Why should we treat varicose veins
Room 0.4/0.5
Moderators: C Wittens, L Kabnick

08h30  

Varicose vein guidelines
P Gloviczki, USA

 08h45

What is the medical rationale for the treatment of varicose veins?
M Meissner, USA

 09h00

Diagnosis and follow-up of varicose veins with duplex ultrasound: how and why?
N Labropoulos, USA

 09h15

Treatment options, clinical outcome and cost benefit in varicose vein treatment
A Davies, UK

Educational grants

VenaCure EVLT – the new gold standard in endovenous ablation
D Carradice, UK

New evolutions in venous ablation
W van Gent, the Netherlands

10h00

BREAK

Which complications in varicose vein treatments have to be consent?
Moderators: A Davies, P Coleridge Smith

10h30

Complications of RFA
I Franklin, UK

10h45

Complications of endovenous laser
L Kabnick, USA

11h00

Complications of foam sclerotherapy
A Cavezzi, Italy

11h15

Lymphatic complications after varicose vein surgery
S Chastanet, France

Educational grants

Histological Findings after Endovenous Radiofrequency Therapy
K Brachmann, Germany

Endovenous Treatment with ClosureFast™.
How it will change your practice
J Lawson, the Netherlands

12h00

LUNCH

The relevance of endovenous treatment in pelvic congestive syndrome.
Moderators: B. Kursat, P Gloviczki

13h00

How does the patho-physiology influence the treatment of pelvic congestion syndrome and
is the result long-lasting?
M Greiner, France

13h15

Pelvic congestion syndrome: a review of current diagnostic and minimally invasive treatment modalities
H Kim, USA

13h30

Debate: A diagnosed PCS can be treated with good long term results.
For: M Perrin, France
Against: P Coleridge Smith, UK

Educational grants

Compression stockings
S Reeder, the Netherlands

14h30

BREAK

Venous Masterclasses
venous area

15h00

Varicose vein diagnostics and treatment

Deep venous thrombosis and deep venous occlusive disease; diagnostics and treatment

Electronic Patients Dossier (EPD) and Registries: the intuitive solution

18h30

COCKTAIL

The best treatment for DVT anno 2011
Room 0.4/0.5
Moderators: T Comerota, N Labropoulos

08h30   

Rationale and indications for aggressive early thrombus removal
M Meissner, USA

08h45

Imaging protocol and LET classification for deep vein thrombosis
C Wittens, the Netherlands

 09h00

Safety and efficacy of catheter-directed thrombolysis
N Baekgaard, Denmark

 09h15

Pharmaco-mechanical thrombectomy for early thrombus removal
A Gasparis, USA

Educational grants

Rheolytic Thrombectomy therapy for acute DVT
A Willis, UK

Catheter intervention for acute venous
thromboembolism
N Kucher, Switzerland

10h00

BREAK

The impaired QoL in Patients with
severe PTS can be improved:
When and How !
Moderators: M Meissner, N Baekgaard

10h30

Incidence and risk factors of PTS
S Kahn, Canada

10h45

Imaging and reproducible scoring system for deep venous pathology using MRV and Duplex
C Arnoldussen, the Netherlands

11h00

Endovenous treatment options for deep venous pathology
R de Graaf, the Netherlands

11h15

Open and hybrid deep vein reconstructions; to do or not to do.
P Gloviczki, USA

What are the requirement for venous stents; can it be realized?
Cees Wittens

11h30

Key note speaker: The future of DVT and PTS in 2020
T Comerota, USA

12h35

EVC in Concert: Quartetto Vasculare (Auditorium 1)
R Brandl, S Debus, S Schellong, M Storck

Does CCSVI exist or is it modern quackery?
Room 0.4/0.5
Moderators: P Gloviczki, E Rabe

14h00

The patho-physiological correlation between CCSVI and MS: rationale of treatment
M Lugli, Italy

14h15

Evolution in quality of life and epidemiological impact after endovascular treatment of CCSVI in patients with MS
R Beelen, Belgium

14h30

Extra- and transcranial echo colour Doppler in the diagnosis of CCSVI
L Visser, the Netherlands

Venous Masterclasses
venous area

15h00    

Varicose veins; diagnostics and treatment

Deep venous thrombosis and deep venous occlusive disease; diagnostics and treatment

Electronic Patients Dossier (EPD) and Registries: the intuitive solution

How to improve and sustain high quality refunded Phlebological care in Europe?
Room 0.4/0.5
Moderators: M Neumann, J Lawson

08h30   

The foundation of an European College of Phlebology
A Davies, UK

08h45

European Phlebology Certificate; why and how to get it.
E Rabe, Germany

09h00

European Electronic Patient Dossiers and Registry; why and how
C Wittens, the Netherlands

09h15

The relevance of the natural history of varicous veins and refunded care.
F Pannier, Germany

Educational grants

Transmural leg ulcer care
L Huisman, the Netherlands

Improvement of venous function by endoluminal thermal ablation with steam
M Jünger, Germany

10h00

BREAK

What should we register to quantify the severity of venous diseases before and after conservative or invasive treatments?
Moderators: M Meissner, A Davies

10h30

CEAP - Gold standard and limits
E Rabe, Germany

10h45

Revised venous clinical severity score: a facile measurement of outcomes in venous disease
M Vasquez, USA

11h00

Villalta scale: goals and limitations
S Kahn, Canada

11h15

Importance of patient-reported outcomes in chronic venous disorders
J J Guex, France

Educational grants

Mechanico-Chemical(Clarivein) treatment for Defiant Venous Ulcers of the Lower Extremities
R Bernstein, USA

tba

12h00

LUNCH

Necessity and refunding of varicose vein surgery for cosmetic complaints.
Moderators: C Wittens, E Rabe

13h00

Psychological impact of cosmetic and non-cosmetic varicose vein disease.
I Wittens, the Netherlands

13h15

Long term Physical and QoL follow-up for different C2 treatments
F Catarinella, the Netherlands

13h30

Debate: All indications for C2 varicose vein treatments should be refunded.
For: J Lawson, the Netherlands
Against: A Davies, UK

Educational grant

14h30

COFFEEBREAK

Venous Masterclasses
Venous area

15h00

Varicose veins; diagnostics and treatment

Deep venous thrombosis and deep venous occlusive disease; diagnostics and treatment

Electronic Patients Dossier (EPD) and Registries: the intuitive solution